2021年获四川大学华西基础医学与法医学院免疫学博士学位，曾获“四川省省优毕业研究生”荣誉称号。目前在四川大学华西基础医学与法医学院从事博士后研究工作，主要研究方向为免疫调节与疾病。作为负责人主持四川大学专职博士后研发基金项目，以第一（含共同）作者在J Cell Physiol、Int Immunopharmacol、Molecules、Transl Oncol等期刊发表学术论文共7篇。在指导本科生创新创业项目以及基础医学创新研究暨实验设计论坛等竞赛方面具有丰富的经验。

主要讲授供基础、临床、预防、口腔等医学类专业用的《医学免疫学》课程，曾在华西基础医学与法医学院举办的第二届青年教师教学竞赛中获“一等奖”。

1. 负责人 主持四川大学专职博士后研发基金项目（2022SCU12030）“IFITM2在胰腺导管腺癌发生发展中的作用及作用机制探索”；

2. 以第一（含共同）作者发表学术论文：

Wang P, Hu J, Min S, Chen C, Zhu Y, Pan Y, Wei D, Wang X. Recombinant Phaseolus vulgaris phytohemagglutinin L-form expressed in the Bacillus brevis exerts in vitro and in vivo anti-tumor activity through potentiation of apoptosis and immunomodulation. Int Immunopharmacol. 2023 Jun 1;120:110322.

Wang P, Hu J, Duan J, Min S, Chen C, Zhu Y, Pan Y, Wang Y, Wei D, Wang X. Preparation of a novel monoclonal antibody against active components of PHA-L from Phaseolus vulgaris and its functional characteristics. BMC Biotechnol. 2022 Oct 29;22(1):32.

Wang P, Leng X, Duan J, Zhu Y, Wang J, Yan Z, Min S, Wei D, Wang X. Functional Component Isolated from Phaseolus vulgaris Lectin Exerts In Vitro and In Vivo Anti-Tumor Activity Through Potentiation of Apoptosis and Immunomodulation. Molecules. 2021 Jan 18;26(2):498.

Wang P, Zhang H, Yang J, Li Z, Wang Y, Leng X, Ganapathy S, Isakson P, Chen C, Zhu T. Mu-KRAS attenuates Hippo signaling pathway through PKCι to sustain the growth of pancreatic cancer. J Cell Physiol. 2020 Jan;235(1):408-420.

Wang Q, Wang P, Zhang L, Tessema M, Bai L, Xu X, Li Q, Zheng X, Saxton B, Chen W, Willink R, Li Z, Zhang L, Belinsky SA, Wang X, Zhou B, Lin Y. Epigenetic Regulation of RIP3 Suppresses Necroptosis and Increases Resistance to Chemotherapy in NonSmall Cell Lung Cancer. Transl Oncol. 2020 Feb;13(2):372-382.

Wang P, Wei D, Zhang H, Chen J, Zhang D, Ganapathy S, Isakson P, Chen C, Zhu T. PKCι and YAP1 are crucial in promoting pancreatic tumorigenesis. Oncotarget. 2018 Aug 28;9(67):32736-32750.